PET staging improves survival of patients with lung cancer

06/27/2013 | AuntMinnie.com (free registration)

Pretreatment PET staging of limited-stage small-cell lung cancer can improve patient survival, according to a study published in the Journal of Thoracic Oncology. PET-staged patients demonstrated three-year overall survival of 47%, while those who were not staged with PET had 19% survival, the study said. Median survival after diagnosis among PET-staged patients was 32 months, while it was 17 months for patients not staged with PET.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC